CD66a (CEACAM1) is the only CD66 variant expressed on the surface of plasma cells in multiple myeloma: A refined target for radiotherapy trials?: Correspondence
(2010)
Journal Article
Lee, C., Guinn, B. A., Brooks, S. E., Richardson, D., & Orchard, K. (2010). CD66a (CEACAM1) is the only CD66 variant expressed on the surface of plasma cells in multiple myeloma: A refined target for radiotherapy trials?: Correspondence. British journal of haematology, 149(5), 795-796. https://doi.org/10.1111/j.1365-2141.2010.08100.x